Abstract:Objective: In the present work, an attempt has been made to mimic Ezetimibe with the design of flexible linear acetamides bearing amino, oxy, and thio groups in beta position as cholesterol absorption inhibitors. Methods: Compounds ( I–VII ) were prepared and analyzed for cholesterol lowering activity in vivo by determining total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglyceride (TG). Results and Discussion: Among the acetamides prepared, compound ( III ) (total cholesterol: 137.5; triglycerides: 93.8; HDL: 55.2; LDL: 81; VLDL: 17.8), and compound ( VI ) (total cholesterol: 134.1; triglycerides: 92.3; HDL: 51.8; LDL: 76.5; VLDL: 17.3) showed excellent in vivo cholesterol lowering activity when compared to all other compounds and even better activity than the standard drug atorvastatin (total cholesterol: 141.7; triglycerides: 95.3; HDL: 57.5; LDL: 83.2; VLDL: 19.5). As a reflection of the cholesterol lowering activities, Wistar albino rats treated with ( III ) and ( VI ) showed a maximum decrease in their body weights, 260.4 and 256.3 g respectively, when compared to all other prepared compounds as well as the standard drug (270.7 g). All the synthesized compounds along with the Ezetimibe were docked with the target enzyme Niemann-Pick C1-like1 (NPC1L1) protein (PDB ID: 3QNT), performed by AutoDock 4.0 tool. Conclusions: The molecular docking analysis demonstrated that ( III ) –4.92 kcal/mol and ( VI ) –5.36 kcal/mol achieved the highest binding affinity scores with good hydrogen bonds and hydrophobic interactions, all contributed to the stabilization of the compounds at the protein's target site.

2-Azetidinone Derivatives: Design, Synthesis and Evaluation of Cholesterol Absorption Inhibitors

Synthesis and Bioactivities of 2-Azetidinones As Cholesterol Absorption Inhibitors

Design and Synthesis of 2-Azetidinone Cholesterol Absorption Inhibitors

Synthesis and Biological Evaluation of Ezetimibe Analogs As Possible Cholesterol Absorption Inhibitors.

Synthesis and Biological Evaluation of 2-Azetidinone Derivatives As Cholesterol Absorption Inhibitors

Design, Synthesis and Biological Evaluation of N,N-3-phenyl-3-benzylaminopropanamide Derivatives As Novel Cholesteryl Ester Transfer Protein Inhibitor

Discovery of Novel N,N-3-phenyl-3-benzylaminopropionanilides As Potent Inhibitors of Cholesteryl Ester Transfer Protein in Vivo.

4-Cf3-ezetimibe Analogs: Design, Synthesis, and Biological Evaluation of Cholesterol Absorption Inhibitions

Ezetimibe Analogs with a Reorganized Azetidinone Ring: Design, Synthesis, and Evaluation of Cholesterol Absorption Inhibitions.

Discovery, Synthesis and Evaluation of Novel Cholesterol Absorption Inhibitors

[Synthesis and AchE Inhibitory Activity of 2-Phenoxy-indan-1-one Derivatives].

New azetidinone cholesterol absorption inhibitors

Synthesis and Biological Evaluation of Isoflavone Amide Derivatives with Antihyperlipidemic and Preadipocyte Antiproliferative Activities.

Lipid Accumulation Inhibitory Activities of Novel Isoxazole-Based Chenodeoxycholic Acids: Design, Synthesis and Preliminary Mechanism Study

( S )- N -Benzyl-1-phenyl-3,4-dihydroisoqunoline-2(1 H )-carboxamide Derivatives, Multi-Target Inhibitors of Monoamine Oxidase and Cholinesterase: Design, Synthesis, and Biological Activity.

1,3,4-Oxadiazoline derivatives as novel potential inhibitors targeting chitin biosynthesis: design, synthesis and biological evaluation.

Research and Development of Β-Lactam Cholesterol Absorption Inhibitors

Synthesis, biological evaluation, and molecular docking studies of xanthone sulfonamides as ACAT inhibitors.

Design, Synthesis and Evaluation of Novel Quinazoline-2,4-dione Derivatives As Chitin Synthase Inhibitors and Antifungal Agents

Design and Synthesis of Linear Acetamides as Cholesterol Lowering Agents

Synthesis and Lipid-Lowering Activity of Phenoxy Acetic Acid Derivatives